Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 6.6B | 5.9B | 6.0B |
Cost of revenue | 3.5B | 4.4B | 3.6B | 3.7B |
Gross profit | 2.4B | 2.2B | 2.3B | 2.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 76M | 88M | 172M | 78M |
Operating income | 1.3B | 1.0B | 1.1B | 1.1B |
Non operating interest income | ||||
Income | 117M | 109M | 156M | 202M |
Expense | 734M | 729M | 795M | 812M |
Other income expense | 21M | 35M | 9M | 85M |
Pretax income | 673M | 459M | 473M | 606M |
Tax provision | 39M | -215M | -106M | 82M |
Net income | 634M | 674M | 579M | 524M |
Basic EPS | 0.3 | — | 0.3 | 0.2 |
Diluted EPS | 0.3 | — | 0.3 | 0.2 |
Basic average shares | 2.5B | — | 2.4B | 2.4B |
Diluted average shares | 2.5B | — | 2.4B | 2.4B |
EBITDA | 2.6B | 2.3B | 2.4B | 2.5B |
Net income from continuing op. | 695M | 674M | 579M | 478M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |